Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Managed care branded OTC reimbursement strategy ill-advised, consultant tells AAPS.

This article was originally published in The Tan Sheet

Executive Summary

BRANDED OTC MANAGED CARE REIMBURSEMENT STRATEGY "SUICIDAL," in the opinion of industry consultant William Howard, PhD. Speaking at the American Association of Pharmaceutical Scientists annual meeting in Boston Nov. 2-6, the founder of the Morris Plains, N.J.-based pharmaceutical software/management firm SDM acknowledged that OTC drugs' potential role in managed care remains a "hot topic" among many in the OTC industry but warned against the pursuit of OTC reimbursement, reasoning that such a scenario often is financially detrimental to both the manufacturer and the managed care organization.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087759

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel